You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Valmet Q2’24: New orders increased
Valmet’s Q2 was neutral as a whole but since the result was weaker than expected, H2 needs to be strong for the company to reach its guidance. In the interview, analyst Antti Viljakainen comments on this, as well as the shorter backlog and longer-term outlook.
00:00 Intro
00:17 Q2 tops & flops
02:48 Can guidance be achieved after soft H1?
04:59 Order increase
05:56 Shorter order backlog
07:25 Expectations for next few years
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
Vis alle videoer